Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatment.
Meng XuHao DengXiaomei ZhangJingwen DengWei YuLing HanYuhong YanDanni YaoJingjie YuShuyan YeJingwen CuiDi HuYan JiaZhining DongDanke XuXiaobo YuChuanjian LuPublished in: Clinical rheumatology (2024)
Serological PI3 is a reliable biomarker for PV diagnosis and may have the potential to predict and monitor the progression of PV before and after treatment. Key Points • This study validated PI3's diagnostic performance in two independent psoriasis cohorts using CLIA. • PI3 expression is significantly correlated with the psoriasis severity and with patients who benefited from the treatments. • Serological PI3 is a reliable biomarker for psoriasis diagnosis and may have the potential to monitor the psoriasis progression with and without treatments.